HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
J Clausen Selected Research
J Clausen Research Topics
Disease
4
Neoplasms (Cancer)
10/2010 - 02/2000
3
Multiple Sclerosis
04/2001 - 03/2001
1
Graft vs Host Disease (Graft-Versus-Host Disease)
06/2023
1
Pain (Aches)
07/2017
1
Proteinuria
07/2009
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2007
1
Type 2 Diabetes Mellitus (MODY)
08/2004
1
Insulin Resistance
08/2004
1
Breast Neoplasms (Breast Cancer)
08/2001
1
Genetic Predisposition to Disease (Genetic Predisposition)
04/2001
Drug/Important Bio-Agent (IBA)
2
Antigens
IBA
06/2007 - 07/2001
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2023
1
Methotrexate (Mexate)
FDA Link
Generic
06/2023
1
Sirolimus (Rapamycin)
FDA Link
07/2009
1
KIR Receptors
IBA
06/2007
1
Ligands
IBA
06/2007
1
Insulin (Novolin)
FDA Link
08/2004
1
2,4-thiazolidinedione (thiazolidinedione)
IBA
08/2004
1
Lipids
IBA
08/2004
1
Lipoproteins (Lipoprotein)
IBA
08/2004
1
Glyburide (Glibenclamide)
FDA Link
Generic
08/2004
1
Pioglitazone (Actos)
FDA Link
08/2004
1
Paclitaxel (Taxol)
FDA Link
Generic
08/2001
1
Epirubicin (Ellence)
FDA Link
Generic
08/2001
1
Cytotoxins (Cytolysins)
IBA
07/2001
1
Monoclonal Antibodies
IBA
07/2001
1
Radioisotopes (Radionuclides)
IBA
07/2001
1
HLA Antigens (Human Leukocyte Antigens)
IBA
04/2001
1
Nucleotides
IBA
04/2001
1
3' Untranslated Regions (3' UTR)
IBA
04/2001
1
HLA-DR15 antigen
IBA
04/2001
1
MHC class II transactivator protein
IBA
04/2001
1
CTLA-4 Antigen
IBA
03/2001
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2000
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
08/2001 - 02/2000
2
Transplantation
07/2017 - 08/2001
1
Therapeutics
10/2010
1
Stem Cell Transplantation
10/2010
1
Hematopoietic Stem Cell Transplantation
07/2009
1
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2007
1
Autologous Transplantation
08/2001
1
Immunotherapy
07/2001